Podcast
Questions and Answers
Describe the course of the development of pre-natal immunity and the defining events associated with these steps.
Describe the course of the development of pre-natal immunity and the defining events associated with these steps.
8 weeks: B cells first appear in the fetal liver and are produced in the bone marrow beginning in the second trimester. 10-30 weeks: Small amounts of immunoglobulin may be detected and the isotopes appear in a certain order (IgM > IgD > IgG > IgA). Fetal Immunity: Protection is derived largely from the position in the womb. Active transport of maternal IgG by FcRn begins around the 16th week. More than 50% of the transfer occurs after the 34th week. Self-Recognition: Tolerance to autoantigens is being established. Intrauterine Infection: The fetus is immunodeficient and may develop varying degrees of tolerance to the infectious organism. Prenatal infection is indicated by the presence of IgM and IgA in the core blood.
Understand the changes that occur in the immune response during life beginning with neonatal immunity and continuing through geriatric immunity.
Understand the changes that occur in the immune response during life beginning with neonatal immunity and continuing through geriatric immunity.
Neonatal Immunity: The neonatal immune system is present, but underdeveloped. Neonates can produce all Ig isotypes, but IgM is predominant. Maternal IgG persists for up to 6 months. Ig metabolism is slower in the neonate, and it is a major source of neonatal immunity. The mother must be immune to protect the child against a specific pathogen. There is no memory to this passive immunity. Childhood Immunity: Two common events shape the acquisition of immunity during childhood: The loss of maternal IgG around 5-6 months is associated with common acute infectious diseases (common childhood infections). Routine pediatric immunizations helps develop active immunity. The immune response is reasonably mature by 2-3 years, but a normal child is immunologically inexperienced.
Know the general trends (not specific numbers) for immunoglobulin levels during life.
Know the general trends (not specific numbers) for immunoglobulin levels during life.
Fetal Stage: IgG is the only antibody that crosses the placenta, providing passive immunity. IgM, IgA, IgE are not produced in significant amounts. Neonatal Period: High IgG levels from maternal transfer initially. Maternal IgG declines rapidly, leaving an "immunity gap" until the infant begins producing its own IgG. IgM production starts shortly after birth. IgA begins production but remains low. Infancy & Early Childhood: IgG production increases, reaching adult levels by ~4-6 years. IgA and IgM gradually increase but remain lower than adult levels. Adulthood: IgG, IgA, IgM reach stable, mature levels. IgE remains low unless influenced by allergies. Geriatric Phase: IgG levels remain stable but may decrease slightly. IgA may increase, particularly in mucosal tissues. IgM levels decline. Immune response to new infections and vaccinations weakens due to immunosenescence.
Describe the mechanisms of antibody-mediated immunity to infectious disease: neutralization, opsonization, and complement fixation.
Describe the mechanisms of antibody-mediated immunity to infectious disease: neutralization, opsonization, and complement fixation.
Describe and contrast the characteristics of T Cell antigens vs B Cell antigens.
Describe and contrast the characteristics of T Cell antigens vs B Cell antigens.
Contrast how B Cells see antigens vs how T Cells see antigens.
Contrast how B Cells see antigens vs how T Cells see antigens.
Describe how the basic structure of T Cell receptors is compared to B Cell receptors.
Describe how the basic structure of T Cell receptors is compared to B Cell receptors.
Define the basic identifying surface molecules (CD) on mature T Cells and their function.
Define the basic identifying surface molecules (CD) on mature T Cells and their function.
Summarize the process of negative selection during T Cell development.
Summarize the process of negative selection during T Cell development.
List the CD markers on developing T Cells relative to their developmental stage.
List the CD markers on developing T Cells relative to their developmental stage.
Explain why the terms "double negative" and "double positive" are meaningful during T Cell development.
Explain why the terms "double negative" and "double positive" are meaningful during T Cell development.
Describe the basic structure of the TCR and its accessory molecules.
Describe the basic structure of the TCR and its accessory molecules.
Name the different Classes of TCR.
Name the different Classes of TCR.
Describe in basic terms how a TCR works or transduces signal.
Describe in basic terms how a TCR works or transduces signal.
List the cellular components involved in T Cell signal transduction.
List the cellular components involved in T Cell signal transduction.
Describe Co-stimulation and why it is important.
Describe Co-stimulation and why it is important.
Describe antigen processing relative to MHC class and its relation to binding to the TCR.
Describe antigen processing relative to MHC class and its relation to binding to the TCR.
Define what a Superantigen is.
Define what a Superantigen is.
Describe what a Superantigen does to T Cells and APC.
Describe what a Superantigen does to T Cells and APC.
Define two stages of pathology associated with Superantigen exposure.
Define two stages of pathology associated with Superantigen exposure.
Define and contrast the MHC molecules involved in the interaction of T helper versus killer cells with APC.
Define and contrast the MHC molecules involved in the interaction of T helper versus killer cells with APC.
Describe how T killer cell antigen processing differs from T helper cell antigen processing.
Describe how T killer cell antigen processing differs from T helper cell antigen processing.
List the basic processes required for an APC to activate a T Cell (ie, what has to happen?)
List the basic processes required for an APC to activate a T Cell (ie, what has to happen?)
Define what a T Cell checkpoint is and how it relates to cancer immunity.
Define what a T Cell checkpoint is and how it relates to cancer immunity.
Define the terms "mature" and "naïve" relative to T Cells.
Define the terms "mature" and "naïve" relative to T Cells.
Contrast Th cells (T Helper cells) with T Killer (CTL) cells regarding function.
Contrast Th cells (T Helper cells) with T Killer (CTL) cells regarding function.
Contrast Th cells with CTL with regard to surface markers.
Contrast Th cells with CTL with regard to surface markers.
List the different types of T helper cells.
List the different types of T helper cells.
Recognize the defining cytokines each Th type produces.
Recognize the defining cytokines each Th type produces.
Name at least one characteristic cytokine each Th type produces.
Name at least one characteristic cytokine each Th type produces.
Describe the principal pathogen(s) each Th cell targets.
Describe the principal pathogen(s) each Th cell targets.
Define inflammation
Define inflammation
List the 2 causes of inflammation
List the 2 causes of inflammation
Describe how macrophages initiate inflammation
Describe how macrophages initiate inflammation
Identify 5 proinflammatory cytokines produced by macrophages
Identify 5 proinflammatory cytokines produced by macrophages
Identify interacting partners that allow neutrophils to enter the site of inflammation
Identify interacting partners that allow neutrophils to enter the site of inflammation
Identify 3 mechanisms of action of corticosteroids
Identify 3 mechanisms of action of corticosteroids
List at least 5 side effects of corticosteroids
List at least 5 side effects of corticosteroids
List the 5 monoclonal antibody targets in inflammation
List the 5 monoclonal antibody targets in inflammation
Identify targets for NSAIDs, 5-LOX inhibitors, and LTRAS
Identify targets for NSAIDs, 5-LOX inhibitors, and LTRAS
Describe the polarization of M1 versus M2 microglia
Describe the polarization of M1 versus M2 microglia
Describe the different effects of engagement of CB1 and CB2 receptors
Describe the different effects of engagement of CB1 and CB2 receptors
Describe the anti-inflammatory mechanism of selective cannabinoid 2 receptor agonists
Describe the anti-inflammatory mechanism of selective cannabinoid 2 receptor agonists
Describe the anatomy and specific cells of the mucosal immune system.
Describe the anatomy and specific cells of the mucosal immune system.
Explain how non-specific and specific factors work in concert to provide protection from harmful pathogens in this system.
Explain how non-specific and specific factors work in concert to provide protection from harmful pathogens in this system.
Describe how the mucosal immune system differs from the rest of the immune system.
Describe how the mucosal immune system differs from the rest of the immune system.
Describe how innate lymphoid cells target specific infections
Describe how innate lymphoid cells target specific infections
Detail the mechanisms by which specific immunoglobulins under the regulation of T cells are produced and mediate mucosal immunity.
Detail the mechanisms by which specific immunoglobulins under the regulation of T cells are produced and mediate mucosal immunity.
Describe how IgA is transported across epithelium and how slgA stays bound to mucous.
Describe how IgA is transported across epithelium and how slgA stays bound to mucous.
Describe how passive transfer of immunity protects infants from infection, including the mechanisms and the timing of exposure to IgG and IgA.
Describe how passive transfer of immunity protects infants from infection, including the mechanisms and the timing of exposure to IgG and IgA.
Flashcards
8 weeks
8 weeks
B cells appear in the fetal liver, and are produced in the bone marrow.
10-30 weeks
10-30 weeks
IgM > IgD > IgG > IgA. Small amounts of immunoglobulin may be detected in this order.
Fetal Immunity
Fetal Immunity
Protection derived largely from the position in the womb. Active transport of maternal IgG by FcRn begins.
Self-Recognition
Self-Recognition
Signup and view all the flashcards
Intrauterine Infection
Intrauterine Infection
Signup and view all the flashcards
Neonatal Immunity (Birth)
Neonatal Immunity (Birth)
Signup and view all the flashcards
Maternal IgG Persistence
Maternal IgG Persistence
Signup and view all the flashcards
Childhood Immunity
Childhood Immunity
Signup and view all the flashcards
2-3 years
2-3 years
Signup and view all the flashcards
Adolescent Immunity
Adolescent Immunity
Signup and view all the flashcards
Adult Immunity
Adult Immunity
Signup and view all the flashcards
Fetal Stage
Fetal Stage
Signup and view all the flashcards
Neonatal Period
Neonatal Period
Signup and view all the flashcards
Infancy & Early Childhood
Infancy & Early Childhood
Signup and view all the flashcards
Opsonization
Opsonization
Signup and view all the flashcards
Viral Neutralization
Viral Neutralization
Signup and view all the flashcards
Blocking Bacterial Attachment
Blocking Bacterial Attachment
Signup and view all the flashcards
Toxin Neutralization
Toxin Neutralization
Signup and view all the flashcards
Complement Fixation
Complement Fixation
Signup and view all the flashcards
B Cell Antigens
B Cell Antigens
Signup and view all the flashcards
T Cell Antigens
T Cell Antigens
Signup and view all the flashcards
B Cells vs T Cells
B Cells vs T Cells
Signup and view all the flashcards
T Cell Receptor
T Cell Receptor
Signup and view all the flashcards
TCR
TCR
Signup and view all the flashcards
CD3
CD3
Signup and view all the flashcards
Negative Selection (T Cells)
Negative Selection (T Cells)
Signup and view all the flashcards
Positive selection (T Cell)
Positive selection (T Cell)
Signup and view all the flashcards
Double Negative
Double Negative
Signup and view all the flashcards
Double positive
Double positive
Signup and view all the flashcards
ADCC
ADCC
Signup and view all the flashcards
Study Notes
Antibody-Mediated Immunity: Prenatal Development
- B cells appear in the fetal liver around 8 weeks, with bone marrow production starting in the second trimester.
- Immunoglobulin can be detected between 10-30 weeks, appearing in the order IgM > IgD > IgG > IgA.
- Fetal immunity relies on the womb environment.
- Maternal IgG is actively transported by FcRn starting around the 16th week, with most transfer occurring after the 34th week.
- Self-recognition, which is the tolerance to autoantigens, is established in the womb.
- If the fetus gets an intrauterine infection or is immunodeficient, it can develop varying degrees of tolerance to the infectious organism.
- A prenatal infection is indicated by the presence of IgM and IgA in the core blood.
Antibody-Mediated Immunity: Neonatal and Childhood
- Neonatal immune system: Present, yet underdeveloped at birth.
- Neonates can produce all Ig isotypes, but IgM is more dominant.
- Maternal IgG persists for up to 6 months in neonates.
- In neonates, the maternal IgG is slower to metabolize
- A mother has to be immune to protect the child against a specific pathogen because there is no memory to this passive immunity.
- Two common events shape the acquisition of immunity during childhood:
- Loss of maternal IgG around 5-6 months is associated with common acute infectious diseases.
- Routine pediatric immunizations help develop active immunity.
- The immune response matures by 2-3 years, but a normal child is still inexperienced until then.
Antibody-Mediated Immunity: Adolescence, Adulthood, and Geriatrics
- Individual immunity grows when encountering everyday immunogenic challenges.
- Serious congenital immunodeficiency may not be found early unless there is other pathology.
- Immunodeficiency usually shows around 3-6 months as maternal immunity fades.
- An atypical reaction to a live vaccine may be the first sign of immunodeficiency.
- Adolescent immunity is affected by environmental factors like culture, geography, socioeconomic status, nutrition, and puberty/hormonal changes, physical changes, drugs/alcohol, sexual maturation, social pressures, and sports/driving.
- The thymus reaches its maximum size (~35 grams) around puberty and slowly involutes, and later a small mass (~6 grams) will remain in adulthood.
- Normal adults are immunologically experienced but contract around 2-5 acute infections a year from new organisms.
- Exposure patterns are mainly influenced by factors in the environment like occupation, hobbies, and geographical location.
- Most adults at age 40-46 only have only 5-10% of their adolescent thymus remaining
- The failure of the immune system itself, is still uncommon.
- Geriatric immunity varies in the elderly due to activity level, genetics, and health conditions.
- Underlying conditions like cancer, heart disease, and metabolic syndrome impact immunity.
- Diet and other lifestyle choices also affects immunity in the elderly.
Immunoglobulin Trends During Specific Life Stages
- Fetal Stage: IgG, the only antibody to provide passive immunity, crosses the placenta; IgM, IgA, and IgE are not produced in significant levels.
- Neonatal Period:
- Maternal IgG levels are initially high, but decrease quickly and leave an "immunity gap" when the infant begins to produce its own IgG.
- IgM production starts soon after birth.
- IgA production starts, but stays low.
- Infancy & Early Childhood:
- IgG production increases and will reach adult levels around 4-6 years.
- IgA and IgM levels will slowly increase as well, but remain below adult levels.
- Adulthood: IgG, IgA, and IgM all gradually reach stable, mature levels, and IgE generally remains low unless allergies are present.
- Geriatric Phase: IgG levels will generally remain stable but may decrease slightly; IgA may increase; IgM levels decline; immune response to new infections and vaccinations weakens due to immunosenescence.
Antibody-Mediated Immunity: Neutralization
- Viral Neutralization occurs when Physical binding of an antibody prevents a virus from attaching to its complementary cell receptor, stopping infection of the cell and is important mechanism of action for flu/influenza vaccines
- Blocking of Bacterial Attachment helps in preventing bacterial infections at mucosal surfaces. Secretory IgA (SIgA) prevents bacterial attachment and penetration by binding and excreting the bacteria-antibody complex.
- Toxin Neutralization occurs when Bacterial toxins cause common toxin diseases but the binding of an antibody can prevents the toxin from binding
Cell-Mediated Immunity: Antigen Recognition
- B Cell Antigens exist in their natural, not processed state, and can be proteins, polysaccharides, lipids, or small chemicals.
- B cells use their receptors, the membrane-bound antibodies, to directly bind to these antigens.
- Since a B Cell's recognition doesn't require antigen processing, B cells can bond with whole pathogens or surface-bound antigens or/and free-floating molecules like toxins.
- T Cell Antigens needs to processed and presented by antigen-presenting cells (APCs), like dendritic cells, macrophages, or B cells.
- Since the T cell antigens are usually peptides that are protein-derived, they must be divided into short chunks and displayed on MHC molecules.
- The T Cell receptors can only interact with peptide-MHC complexes that the antigen expresses.
T Cell Differentiation Subtypes
- CD4+ helper T cells release cytokines that activate other immune cells, coordinate immune responses. THey recognize MHC-II bound peptides
- CD8+ cytotoxic T cells can directly eliminate infected or cancerous cells. THey recognize MHC-I bound peptides
B Cell Receptor vs T Cell Receptor
- B Cell Receptors (BCR) recognize unprocessed antigens from the body
B Cell Receptor Structure
- B Cell Receptors (BCR) are membrane-bound and secrete as antibodies when B cells differentiate into plasma cells. the receptors Made of two identical heavy chains and two identical light chains that are connected by disulfide bonds, giving a total of 4 polypeptide chains. The receptors consist of both a variable region (V) for antigen binding and a constant region (C) for structural support.
T Cell Receptor Structure and Function
- T Cell Receptors (TCR) must be membrane-bound
- T cell receptors consist of heterodimers, which is made of heterodimers and of one alpha/beta chain that must be linked by disulfide bonds. the receptors consist of both a variable region (V) for antigen binding and a constant region (C) for structural support.
T Cell: Surface Markers
- T Cell Receptor are protein heterodimers that can only occur in the presence of processed immunogen recognition.
- CD3 complex acts as a protein heterdimer that can be used for immunogen recognition
- CD:4 acts like protein for MHC Class 2 Recognition
Positive and Negative T Cell Selection
- Negative selection deletes autoreactive clones to ensure tolerance to self-antigens
- Negative selection makes sure that cells dont target the body
- Tight Antigen binding means death
- Moderate Antigen binding meand survival
- Positive Selection ensures that the T cell receptor recognizes the self-MHC -Weak/no Antigen binding = death -Moderate/Strong Antigen Binding = survival
T Cell Marker: Stage of Development
- Double Negative Stage of a T cell when there is no CD4/8 expression; Receptor expression begins
- Double Positve state of T cell when there is both CD4/8 expression; T Cell Receptor Increases
- Immunogenic Selection includes a Deletion of autoreactive clones with self-antigens and tolerance to self-antigens
- Single Postive state of T Cell when there is either CD4 or CD8 expressed and will become mature T Cells
Superantigens
- Cause excessive and non-specific T Cell stimulation by binding to MHC Class 2 Molecules/T Cell Receptors
- A typical APCs will use MHC 2 to process T cells but superantigens will bypass and bind to cells directly leading to the release of a massive surge of cytotokines.
- Superantigens can cause widespread inflammation, tissue damage, systemic toxicity (Superantigen exposure)
Superantigens- Pathology Stage
- Superantigens Non-specific binding to MHC-II/ TCR causing massive number of activated T Cells, leading to Cytokine release -Improper co-stimulation prevents normal immune regulation, cytokine storm worsens
- T cells become non-responsive due to a lack of secondary signals (Massive activation), leads to immune Supression - High risk of secondary infections
CD Types and Interaction
- MHC Class 1 interacts w/ KIller T cells - Antigen can be viruses/cancers - Will only ever recognize cd8+ T Cells - Creates Cytotoxic Immune response
- MHC Class 2 interacts w/ helpwer T cells - Antigen can be bateria/Fungi - Will only ever recognize cd4+ T cells - Creates helper cytokin release
- CD and MHC have the same goal of having the cells communicate to cause an immune response
Types of T Killers
- Intracellular-antigen/chopped-into-pepides/MHC class 1 (Ag on cell surface presenting pep w/ viral origin).
- Extracellular-endocytosed in vessles (Golgi/MHC class II molecules).
- Need co-stim for full activation. THO w/ correct stim will cause cytokine signaling (activate killing) in CD8/helper cytokines- CD4
Th Cel Types
- Th2: Parasite/allergy response (extracellular pathogens).
- TH1 primary involved in mediataing of defense against intracellular pathogens - Can be inflammatory
- Tfh primary responsbile for assisting B Cells
- T Reg inhibits responses to maintain immune tolerance and prevent autoimmune
Th cell/Treg
- T helper stimulates response/ T regulat suppress, to ensure that system focus and prevents confusing or stimulating activation - Th1 targets intracellular bactria/parasites -Both stimulate- could weaken
- Th-0 Cells - DC presents and relays cyctokines. The DC will cause this by recohnizing TGR + present antigen on McII to the th-0
- IL-12- becomes th-1. IL-2/ INFy. parasitic/allergy, can activate/ kill cd2/m-Kill, IL6- will suppress tcell death
Monocolonal Antibodies in inflammation
- Anikinra- IL-1 R antagonist, and will block signaling
- Adalinumab-anti-TNFa binds (RA/psoriasis).
- Th2- anti IL 5/ allergy
- Steroids/Non-Steroidals, block 2 main path/ stop inflammation: Non selective/COX 2 selective and 5 lox inhibitors stop leukotriene activation
Mucosal Immunity
- Mucosal immunity can only occur in Gut/Bronchus. Lymphnodes are: - - gult / balt (follics) -tonsils,adeniods, peyers patch, lamina propria
- In immunity/pathogens.
- non-specific factors need to be functioning (Physical/Chemical /micorbiological) immunity has cells to respond, produce immune responses to antigens
- In Imune system, Antigen receptions are received via epithielium, system gets then through lymp/blood
- Tcells have Specialized mech for immune responses/.homing/anti inflammatory bias mech ( IgA and T reg cells that minimalize inflam damage)
Cytokines
- Cytokines small/ act intercell messy/ regulat imune/ function concen/ Autocrine.
- PLeotropy: single cytokine w/ mult effects
- 5 Ways Cyptokes function in body - Cytokines work w/ complex sign network/interactions.
- Cytokines - - IFNS/ IL-8 has lots for immune factors
- Alpha/Beta: antviral def
- Gamma -enhances macrocyte activity
- What happens w/ inf/ injury - Cdfs act/diff of myeloid, stimulate production/different of wbvs, acvt/stim innat immuntiy
- Il2 supports growth, IL 21 helps B Cell. INFs upregulate 1/ll McH. II 4 helps eosinophils. IL3 aids cell gwroth/ IL-3:
Cyokine Receptors
Cytokine Rec begin- Ctyokine bines and cuases di/olgo dimer
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.